Two TB survivors fight Johnson & Johnson monopoly bid

At present, only 2% of over 1.47 lakh patients suffering from multi drug resistant TB in India are currently getting Bedaquiline.

from Healthcare/Biotech-Industry-Economic Times http://bit.ly/2E1wJAs
via IFTTT